You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 6, December 1965 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Marfan's Syndrome

Hematological Abnormalities in a Family

J. WORTH ESTES, MD; ROBERT J. CAREY, MD; RAJENDRA G. DESAI, MD, PhD

Arch Intern Med. 1965;116(6):889-893.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

ABNORMALITIES of hemostasis have been described in patients having heritable disorders of connective tissue, namely the Ehlers-Danlos syndrome, osteogenesis imperfecta, pseudoxanthoma elasticum, and Marfan's syndrome.1-20 Qualitative platelet defects have been found in osteogenesis imperfecta 13,14 and subjects with the May-Hegglin anomaly, whereas factor VIII (antihemophilic factor, AHF) deficiency has been associated with Marfan's syndrome.15,16 This report is concerned with several members of a family with Marfan's syndrome in whom morphological, functional, and biochemical abnormalities of platelets and polymorphonuclear neutrophils were observed.

Methods

Various hematological tests, namely hemoglobin determination, hematocrit, total and differential white cell counts, and platelet counts (phase contrast method) were done by routine methods. Coagulation tests included clotting time, tourniquet test, prothrombin time, prothrombin consumption, thromboplastin generation test (TGT) using platelet substitute,21 and recalcification time of platelet-rich plasma22 to estimate platelet factor 3 (thromboplastic activity). Clot retraction was estimated semiquantitatively 24 hours after blood was withdrawn.28 A few . . . [Full Text PDF of this Article]


Author Affiliations

BOSTON

From the Department of Hematology, University Hospital, Boston.


Footnotes

Submitted for publication March 20, 1965; accepted Aug 13.

Reprint requests to 750 Harrison Ave, Boston, Mass 02118 (Dr. Estes).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1965 American Medical Association. All Rights Reserved.